Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-13
SponsorRhode Island Hospital
About this trial
The goal of this clinical trial is to learn if this intervention (Social Skills, Problem Solving, emotion Regulation, and psycho-Education on Trauma: A Trauma-Informed Peer Aggression and Teen Dating Violence Prevention Program; SPARE) can treat peer aggression and prevent teen dating violence in preteens receiving intensive mental health services. The main questions it aims to answer are:
* Does receiving SPARE reduce proactive and reactive aggression at post-intervention and 3- and 9-month follow-ups? * Does receiving SPARE reduce positive attitude about TDV, prevent TDV behaviors, and improve mental health outcomes at post-intervention and 3- and 9-month follow-ups?
Researchers will compare youth receiving SPARE to youth receiving treatment as usual to see if SPARE results in improved proactive and reactive aggression, TDV attitudes and behaviors, and mental health outcomes.
Participants will:
* Receive SPARE via group therapy incorporated into their daily programing at an intensive mental health program * Complete study questionnaires at program intake and discharge as well as at 3-month and 9-month follow-up assessments
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(1) aged 11-13 years
(2) enrolled in CP,
(3) ability to write and speak in English
(4) parent/guardian consent.
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Experimental: Intervention (SPARE) plus Treatment as Usual
Behavioral5 components: (1) Social skills training, including selecting healthy friends and partners, (2) Problem solving with emphasis on positive outcomes of nonaggressive solutions, (3) Awareness of domineering behavior in self and conflict resolution skills, (4) emotion Regulation, and (5) psycho-education on ACEs and trauma. Each session will include 30 minutes of didactic instruction on the component with developmentally engaging activities to illustrate concepts and an individually tailored 15-minute narrative and mindfulness activity, which may address a traumatic memory depending on youth need and receptivity.
Treatment as Usual (TAU)
BehavioralTreatment As Usual consists of individual, family, occupational, and art therapy, social skills and emotion regulation groups, and therapeutic milieu. All staff and clinicians are trained in the Incredible Years Parenting Program, which aims reduce behavioral problems, enhance children's social and emotional competence, and improve child-parent interactions. Children also receive individualized treatment tailored for their needs (e.g., sleep interventions). Behavioral health needs staff (BHS) facilitate children's skill acquisition and generalization, implement individualized behavior contingency programs, and assist caregivers with parenting strategies via daily check-ins
Treatment groups
88 Participants
are divided into 2 treatment groupsGroup A: Intervention (SPARE) plus Treatment as UsualExperimental treatment 1 intervention
Group B: Treatment As UsualActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Proactive and Reactive Aggression Questionnaire (PRA)
6 items; 2 subscales to assess proactive and reactive aggression; preteen self-report and parent-report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow upSecondary outcomes
1
Acceptance of Couple Violence (ACV)
11 items; 2 subscales that assess acceptance of male-to-female violence and female to male violence; preteen self-report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up2
Conflict in Adolescent Dating and Relationship Inventory (CADRI)
35 items; 5 subscales that assess physical abuse, relational abuse, sexual abuse, threatening behavior, verbal-emotional
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up3
Digital Relationship Behaviors (DRB)
32 items; 4 subscales assessing victimization and perpetration of Threatening/Coercive Behavior and Monitoring Behavior
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up4
Children's Depression inventory (CDI-2)
28 items for self-report; 17 items for parent report; Depression measure; preteen self-report; parent report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow upOther outcomes
1
PROMIS Peer Relations-Short Form
8 items; 2 subscales assessing friendship quality and peer acceptance; preteen report; caregiver report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up2
Problem-Solving Measure for Conflict (PSM-C).
6 items; Assesses problem solving skills, Child report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up3
Conflict Resolution Style Inventory (CRSI)
20 items; 5 subscales assessing styles of Competing, Avoiding, Accommodating, Compromising, and Collaborating; preteen report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up4
Children's Emotion Management Scale (CEMS)
33 items; 3 subscales assessing emotion regulation of anger, sadness, and worry; Child and parent report
Time frame
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Rhode Island Hospital
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov